Table 2.
Comparing the counts and frequencies of immune cells on admission between T2DM and non-T2DM cases.
| Total | T2DM | Non-T2DM | p value | |
|---|---|---|---|---|
| n = 20 | n = 9 | n = 11 | ||
| Total T lymphocytes (%) | 70.4(56.6–76.2) | 69.0(53.7–75.7) | 71.4(60.1–76.9) | 0.569 |
| Total T lymphocytes count (106/L) | 640.5(396.3–1219.3) | 448.0(193.0–587.0) | 962.0(652.0–1,399.0) | 0.002 |
| Decreased, <955, n/N (%) | 14(70.0%) | 9(100.0%) | 5(45.5%) | 0.014 |
| <400, n/N (%) | 5(25.0%) | 4(44.4%) | 1(9.1%) | 0.127 |
| Total B lymphocytes (%) | 17.2(8.9–19.7) | 19.9(13.4–36.4) | 13.3(7.9–17.5) | 0.025 |
| increased, n/N (%) | 8(40.0%) | 6(66.7%) | 2(18.2%) | 0.065 |
| Total B lymphocytes count (10*6/L) | 135.5(65.5–258.3) | 72.0(27.0–261.0) | 141.0(103.0–269.0) | 0.239 |
| decreased, n/N (%) | 7(35.0%) | 5(55.6%) | 2(18.2%) | 0.160 |
| CD4+T cells (%) | 39.0(27.7–50.3) | 29.5(25.7–58.3) | 39.5(28.6–48.9) | 0.970 |
| CD4+T cells count (106/L) | 368.5(201.0–661.8) | 204.0(95.0–395.5) | 583.0(345.0–872.0) | 0.007 |
| decreased, n/N (%) | 13(65.0%) | 8(88.9%) | 5(45.5%) | 0.070 |
| CD8+T cells (%) | 22.2(17.3–36.5) | 23.6(13.2–36.4) | 21.7(20.1–37.8) | 0.569 |
| CD8+T cells count (106/L) | 248.0(125.8–379.0) | 115.0(38.0–238.0) | 352.0(248.0–522.0) | 0.002 |
| decreased, n/N (%) | 12(60.0%) | 8(88.9%) | 4(36.4%) | 0.028 |
| NK cells (%) | 11.4(4.6–23.67) | 10.3(3.5–12.3) | 14.4(10.2–28.9) | 0.074 |
| NK cells count (106/L) | 148.0(34.3–258.8) | 35.0(7.5–99.5) | 252.0(182.0–326.0) | 0.004 |
| Decreased, <150, n/N (%) | 10(50.0%) | 8(88.9%) | 2(18.2%) | 0.005 |
| <77, n/N (%) | 8(40.0%) | 6(66.7%) | 2(18.2%) | 0.065 |
| T+B+NK(%) | 99.3(98.9–99.5) | 99.3(98.9–99.4) | 99.4(98.7–99.6) | 0.761 |
| T+B+NK(#) | 984.5(695.3–1,693.5) | 685.0(241.0–899.0) | 1584.0(1016.0–1795.0) | 0.002 |
| Th/Ts | 1.6(0.9–2.4) | 1.8(0.7–4.8) | 1.4(1.0–2.4) | 0.970 |